ACTIVASE 50 MG Injection
- RxCUI
- 1804806
- RxNorm name
- ACTIVASE 50 MG Injection
- Display name
- ACTIVASE 50 MG Injection
- Full name
- ACTIVASE 50 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103172 | Activase | alteplase | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Activase | ALTEPLASE | Genentech, Inc. | c669f77c-fa48-478b-a14b-80b20a0139c2 | 2026-01-20 | Warnings, Adverse reactions | 1804806 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c669f77c-fa48-478b-a14b-80b20a0139c2 | ACTIVASE 50 MG Injection [PSN] · alteplase 50 MG Injection [Activase] [SBD] · Activase 50 MG Injection [SY] | 3 | 15 | These highlights do not include all the information needed to use ACTIVASE safely and effectively. See full prescribing information for ACTIVASE. Activase (alteplase) for injection, for intravenous use Initial U.S. Approval: 1987 | 20260120 |